Companies already attending......

Pfizer, Astrazeneca, Merck, Roche, Novartis, Organon, Wyeth, Altana Pharma, Bayer Healthcare, Ipsen, Schwarz Biosciences, Organon, Boehringer-Ingelheim, Merck Sharp & Dohme and many many more!

Don't miss you - Make sure you are there as well!  Register now!

HARD-HITTING CASE STUDIES AND INTERACTIVE SESSIONS WITH DRUG SAFETY INDUSTRY EXPERTS

• REAL-LIFE SUCCESSFUL CASE STUDIES: Take-away solutions from industry experts on how to implement and monitor effective pharmacovigilance, risk management and post-marketing studies
  
  
• REGULATORY DEVELOPMENTS: Anticipate regulatory changes for the fast and efficient submission of safety data
  
  
• TECHNOLOGY UPDATE: Benefit from the latest timeframes showcasing how your business can demand efficiancies from EDC systems and textmining software
  
  
• HARNESS SAFETY DATA: Discover how to leverage data from internal databases and registries and how to integrate them for successful risk management plans
  
  
• CUTTING-EDGE DATA ANALYSIS TECHNIQUES: Gain the latest practical advice for enhancing your risk management and pharmacovigilance plans
  
  
• OVERCOME DRUG SAFETY OBSTACLES: Identify the most effective drug safety data systems to ensure compliance with EU regulations, directives and guidelines
  
  
• INNOVATIVE STRATEGIES: Discuss pioneering tactics for enhancing your drug safety knowledge management and building winning communication channels

Speakers already confirmed for this conference include:  Astrazeneca, Pfizer, Sanofi-Aventis, Ipsen, Bayer, The German Pharmaceutical Association (BPI), Quintiles, Aris Global, Boehringer-Ingelheim, Boots Healthcare, Wyeth, Paul-Enrich Institute, MEMO and the University of Montreal.

Book now to take advantage of our early bird offer!
Save €150 and get 1 night's free accommodation!
Register before 7th October.

For the latest programme, please contact Izzy Wakeling , Conference Director iwakeling@eyeforpharma.com or on +44 20 73 75 75 22 .